share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Sulzberger Gabrielle

SEC announcement ·  Apr 17 04:16
Summary by Futu AI
Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of 13 shares of common stock on April 15, 2024. The transaction was carried out directly with the shares acquired at a price of $750.77 each. Following this transaction, Sulzberger's direct holdings in the company increased to a total of 2,128 shares. The acquisition reflects a transaction value of approximately $9,760.01, based on the purchase price. This transaction was classified as a grant, award, or other acquisition, as per the transaction code description provided.
Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of 13 shares of common stock on April 15, 2024. The transaction was carried out directly with the shares acquired at a price of $750.77 each. Following this transaction, Sulzberger's direct holdings in the company increased to a total of 2,128 shares. The acquisition reflects a transaction value of approximately $9,760.01, based on the purchase price. This transaction was classified as a grant, award, or other acquisition, as per the transaction code description provided.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.